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ARTICLE
MDC1 PST-repeat region promotes histone H2AX-
independent chromatin association and DNA
damage tolerance
Israel Salguero 1, Rimma Belotserkovskaya 1,4, Julia Coates1,4, Matylda Sczaniecka-Clift1, Mukerrem Demir1,
Satpal Jhujh 1,3, Marcus D. Wilson 2 & Stephen P. Jackson 1*
Histone H2AX and MDC1 are key DNA repair and DNA-damage signalling proteins. When
DNA double-strand breaks (DSBs) occur, H2AX is phosphorylated and then recruits MDC1,
which in turn serves as a docking platform to promote the localization of other factors,
including 53BP1, to DSB sites. Here, by using CRISPR-Cas9 engineered human cell lines, we
identify a hitherto unknown, H2AX-independent, function of MDC1 mediated by its PST-
repeat region. We show that the PST-repeat region directly interacts with chromatin via the
nucleosome acidic patch and mediates DNA damage-independent association of MDC1 with
chromatin. We ﬁnd that this region is largely functionally dispensable when the canonical
γH2AX-MDC1 pathway is operative but becomes critical for 53BP1 recruitment to DNA-
damage sites and cell survival following DSB induction when H2AX is not available. Con-
sequently, our results suggest a role for MDC1 in activating the DDR in areas of the genome
lacking or depleted of H2AX.
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Cells are constantly subjected to a plethora of exogeneousand endogenously-derived DNA damaging agents. Amongthe different kinds of DNA damage, double-strand breaks
(DSBs) are considered to be the most dangerous lesions, as they
can trigger cell death, mutations and genome rearrangements,
and can contribute to the development of cancer1–3. To protect
the genome from DSBs, cells have evolved various proteins that
are recruited to damaged chromatin regions to engage DNA
repair processes and to trigger a signalling cascade that, amongst
other things, can induce cell death or temporary or permanent
delays in cell cycle progression. Collectively, these DNA repair
and associated signalling events and outcomes can be referred to
as the DNA damage response (DDR)1,2.
In most current models, DSB signalling is initiated by the
MRE11-RAD50-NBS1 (MRN) complex, which senses and binds
to DSB regions, and then recruits and activates the protein kinase,
ATM (Fig. 1a; ref. 4). Next, ATM phosphorylates Ser-139 of
histone H2AX in the chromatin surrounding the DSB site, with
this phosphorylated H2AX (γH2AX) then creating a docking site
for the tandem BRCT domain of the DDR mediator protein
MDC15. Because MDC1 is constitutively bound to NBS1 via its
phosphorylated SDTD region6–9, it draws in more MRN-ATM
complex to the vicinity of the DSB, thereby contributing to
ampliﬁcation of ATM recruitment and activation, and to
spreading of γH2AX-MDC1 on adjacent chromatin. Further-
more, upon recruitment to DSB-associated chromatin regions,
MDC1 is phosphorylated on a set of TQXF motifs by ATM,
thereby creating docking sites that recruit the ubiquitin E3 ligase
RNF810,11, which then ubiquitylates proteins in the vicinity and
thereby triggers recruitment of another E3 ligase, RNF168 (there
is currently debate over whether the relevant protein targeted by
RNF8 is histone H112 or L3MBTL213). Once RNF168 is localised
to the DSB region, it ubiquitylates histone H2A, leading to
recruitment and retention of DNA repair factors such as
53BP114–17 and its downstream effectors including RIF1, PTIP
and the recently identiﬁed Shieldin complex18. Notably, it seems
that the same or similar mechanisms leading to 53BP1 accrual at
ionising radiation (IR) induced foci (IRIF) also mediate 53BP1
recruitment to assemblies called nuclear bodies (NBs) in G1
phase cells. These NBs appear to represent sites of DNA/chro-
matin damage arising when cells progress through mitosis in the
presence of unreplicated DNA regions, as evidenced by their
numbers being elevated when cells are treated with the DNA-
replication inhibitor aphidicolin (APH)19–21. Signiﬁcantly, while
the full DSB signalling cascade happens in interphase cells, if
mitotic cells sustain DSBs, the process is blocked at the stage of
RNF8 recruitment22–25. This is achieved by mitotic phosphor-
ylations in RNF8 and 53BP1 that inhibit their recruitment to
MDC1 and H2A, respectively, and thereby prevent formation of
telomere fusions and consequent chromosome missegregations26.
Nevertheless, recruitment of MDC1 to DSBs in mitosis seems to
be important to maintain genome stability, with recent work
showing how this, at least in part, relies on MDC1 interacting
with TOPBP1. It has been proposed that in these circumstances,
TOPBP1 and MDC1 may play a bridging role to keep the two
DSB ends in close proximity to facilitate their repair in the
ensuing G1 phase27.
In line with the γH2AX-MDC1 interaction being fundamental
for accumulation of DSB repair and signalling factors on chro-
matin in the vicinity of DSBs, H2AX and MDC1 knockout mice
display similar phenotypes: growth retardation, male infertility,
immune defects, chromosome instability and IR hypersensitivity
at both the organism and cellular levels28,29. Moreover, human
cells lacking either MDC1 or H2AX exhibit defects in DSB sig-
nalling and DNA-damage checkpoint activation30–33. However,
while deletion of the gene for H2AX (H2afx) in mice was
reported to enhance tumour formation only in a p53-null back-
ground34,35, Mdc1 knockout mice were reported to display a
higher frequency of tumours even in the presence of p53 func-
tion30. These observations raise the possibility that there might be
an additional, H2AX-independent function(s) for MDC1.
DDR signalling
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Fig. 1 MDC1 loss causes greater IR sensitivity than H2AX loss. a Diagram
depicting the main events in the signal transduction pathway that leads to
53BP1 accumulation on chromatin at DNA-damage sites: (1) DSB induction
and MRN/ATM recruitment/activation. (2) ATM phosphorylates H2AX and
this is recognised by MDC1, which brings in more MRN and ATM. (3) MDC1-
mediated accumulation of ATM results in ampliﬁcation of the γH2AX signal
and, consequently, further recruitment of MDC1/MRN/ATM. (4) ATM also
phosphorylates the TQXF cluster of MDC1. (5) Phosphorylated TQXF motifs
are bound by RNF8, which ubiquitylates another protein(s). (6) This
ubuiqitylated protein(s) serves as a docking site(s) for RNF168. (7) RNF168
ubiquitylates H2A/H2AX and this, together with constitutive histone H4-
K20-methylation, creates a platform that recruits 53BP1 and the Shieldin
complex. b Clonogenic survival assays towards ionising radiation (IR) in
speciﬁed RPE-1 genetic backgrounds. The tendency for MDC1−/− H2AX−/−
double knockout cells to be slightly more IR sensitive than MDC1−/− single
knockout cells might be explained by 53BP1 binding γH2AX in a MDC1-
independent fashion37,38,57 and/or by replication stress caused by the lack of
H2AX33 ; n= 6/genotype (except for MDC1 KO n= 4); error bars s.e.m.
Additional supporting data, including validation, genotyping and cell cycle
proﬁling of knockouts, are presented in Supplementary Fig. 1
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Here, by generating and characterising human cells precisely
deleted for the MDC1 and/or H2AFX (hereafter H2AX) genes, we
show that MDC1 and H2AX are not equivalent in their ability to
convey IR resistance. Furthermore, we document that MDC1 is
able to promote the recruitment of 53BP1 to DSB sites in a
γH2AX-independent manner. This ability requires the proline-
serine-threonine rich PST region of MDC1 whose DDR role has
hitherto been unclear. We also show that this PST-repeat region
binds to nucleosomes, and thereby mediates constitutive asso-
ciation of MDC1 with chromatin, a function that becomes critical
for IR resistance in the absence of H2AX.
Results
MDC1 enhances IR survival even in the absence of H2AX.
While the current model for recruitment of DDR proteins to DSB
sites (Fig. 1a) implies that loss of H2AX or MDC1 should be
functionally equivalent, no direct comparison has to our knowl-
edge been reported. To address this issue, we used CRISPR-Cas9
genome engineering to create both single- and double-knockouts
for the genes for these factors in the otherwise isogenic back-
ground of non-transformed human RPE-1 hTERT cells (Sup-
plementary Fig. 1a, b). After ﬁrst observing that none of these
mutant cell lines presented substantial alterations in their cell
cycle distributions or S-phase progression (Supplementary
Fig. 1c), we tested the sensitivities of various cell clones to IR.
Perhaps surprisingly, while only very mild hypersensitivity was
observed in the case of H2AX−/− cells, considerably more pro-
nounced IR hypersensitivity was exhibited by both MDC1−/−
single knockout and MDC1−/− H2AX−/− double knockout cells
(Fig. 1b; Supplementary Fig. 1d). We thus concluded that, con-
trary to our expectations, MDC1 must have a DDR function that
is independent of its interaction with histone H2AX.
To gain insights into the mechanism(s) underlying the
differences in IR sensitivity between the H2AX−/− and the
MDC1−/− knockout cells, we ﬁrst examined IR-induced phos-
phorylation events on DNA-PKcs, KAP1 and CHK2 (Supple-
mentary Fig. 1e). This analysis revealed no overt differences
between the H2AX−/−, MDC1−/− and H2AX−/−MDC1–/−
genetic backgrounds, suggesting that the IR hypersensitivity of
MDC1 mutant cell lines was not caused by major defects in the
phosphorylation cascade induced by IR.
H2AX-independent effects of MDC1 on 53BP1 DNA-damage
accrual. In light of our ﬁndings and because MDC1 is known to
be crucial for 53BP1 recruitment to DNA damage regions, we
noted that previous reports have documented H2AX-
independent recruitment of 53BP1 to DNA-damage sites33,36.
Indeed, we found that 53BP1 accumulation in NBs was highly
effective in the absence of H2AX (Fig. 2a, b; APH). Nevertheless,
although the proportion of H2AX−/− cells containing NBs was
similar to that of wild-type cells, the number NBs per cell was
lower in the H2AX−/− background (Supplementary Fig. 2a).
Given that neither the size nor the staining intensity of 53BP1
NBs seemed to be decreased by the lack of H2AX, the lower
number of NBs per cell in the absence of H2AX could reﬂect the
existence of different types of lesions generating NBs, with some
but not other types being amenable to H2AX-independent 53BP1
accumulation. Notably, while 53BP1 IRIF formation was reduced
by H2AX inactivation, IRIF still clearly formed in some H2AX−/−
cells (Fig. 2a, b; IR; Supplementary Fig. 2a, bottom panel).
Although we do not have a full explanation for the differential
effects of H2AX loss on NBs and IRIF, we note that H2AX-
independent IRIF frequently occur in G1 cells (Supplementary
Fig. 2b), the cell cycle stage in which NBs are evident. It may thus
be that G1 cells more easily mediate 53BP1 accumulation and/or
retention in the absence of H2AX than do cells in other cell-cycle
stages. Alternatively, the distinct nature of the underlying lesions
in 53BP1 IRIF and 53BP1 NBs—DSBs generated directly by
IR versus DSBs arising during mitosis in unreplicated DNA
regions—could account for the differences observed. Most cru-
cially, we found that unlike the situation in response to H2AX
loss, localisation of 53BP1 to both NBs and IRIF was strongly
diminished by MDC1 loss (Fig. 2a, b; Supplementary Fig. 2a; the
residual 53BP1 recruitment to NBs in MDC1−/− cells might
reﬂect the ability of 53BP1 to bind γH2AX directly37,38). Fur-
thermore, we observed that 53BP1 NBs and residual IRIF in
H2AX-deﬁcient cells were totally abolished by MDC1 inactiva-
tion (Fig. 2a, b; Supplementary Fig. 2a).
H2AX-independent association of MDC1 with NBs requires
53BP1. In light of our ﬁndings, we assessed for enrichment of
MDC1 at sites of DNA damage in either the presence or absence
of H2AX. While no MDC1 IRIF were observed in H2AX−/− cells,
clear accumulation of MDC1 in NBs was detected in this setting
(Fig. 2c). To explain the different responses in NBs and IRIF, we
speculate that the features of NBs that allow recruitment of large
amounts of 53BP119,20 may facilitate the accumulation of MDC1
even in H2AX−/− cells. Supporting this hypothesis, it has been
reported that MDC1 and 53BP1 can directly interact in a manner
mediated by the tandem BRCT region of MDC139. To assess if
this interaction might be responsible for the MDC1 enrichment at
NBs in H2AX−/− cells, we used small interfering RNA
(siRNA) treatments to deplete 53BP1 from such cells and control
H2AX+/+ cells. While 53BP1 depletion did not produce any
apparent effect on MDC1 NB association in H2AX+/+ settings, it
markedly reduced the frequency, and especially the extent, of
MDC1 accumulation at NBs in H2AX−/− cells (Fig. 2d; Supple-
mentary Fig. 2c, d). Similar effects were observed following
siRNA depletion of RNF8, which is required for 53BP1 accrual at
DNA-damage sites10,11. By contrast, depleting either of two
components of the Shieldin complex, SHLD1 and SHLD2, did not
markedly affect NB formation by MDC1 in H2AX−/− cells
(Fig. 2d; Supplementary Fig. 2c, d). Collectively, these data
indicated that 53BP1, but not SHLD1/2, is crucial for MDC1
recruitment and/or retention at NBs speciﬁcally in H2AX-
deﬁcient cells.
The MDC1 PST region promotes the DDR in the absence of
H2AX. Having established that localisation of 53BP1 to DNA
damage sites depends on MDC1 in cells lacking H2AX, we next
examined which of the structural and functional domains of
MDC1 are needed for this (Fig. 3a)40. Thus, we complemented
MDC1−/− single and MDC1−/− H2AX−/− double knockout cells
with green-ﬂuorescent protein (GFP)-tagged wild-type or mutant
versions of MDC1 individually lacking each of the domains, then
assessed 53BP1 accumulation at NBs arising after aphidicolin
treatment. Deleting the MDC1 SDTD region only produced a
small reduction in the number of NBs per cell in the H2AX−/−
mutant background (Supplementary Fig. 3a, b) and no detectable
effect on the percentage of cells containing 53BP1 NBs (Fig. 3b).
By contrast, mutating Thr residues of the MDC1 TQXF cluster to
Ala (AQXF) almost completely abrogated 53BP1 localisation to
NBs in a manner that was not dependent on H2AX status
(Fig. 3b; Supplementary Fig. 3a, b). This effect was as expected
because the Thr residues in the TQXF motifs are phosphorylated
by ATM to generate binding sites for RNF8, which is crucial for
effective 53BP1 recruitment10,11. We also found that deleting the
MDC1 tandem BRCT domain reduced 53BP1 NB formation
independently of H2AX−/− status (Fig. 3b; Supplementary
Fig. 3a, b). We speculate that this effect likely reﬂects the MDC1
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BRCT region not only binding γH2AX, but also recruiting 53BP1
to NBs via a direct interaction with 53BP139. In addition, we
observed that deleting the MDC1 FHA domain reduced 53BP1
NB formation in both H2AX+/+ and H2AX−/− cells (Fig. 3b;
Supplementary Fig. 3a, b). Previous work has shown that the
MDC1 FHA domain promotes MDC1 oligomerization and
thereby potentiates IRIF formation by it and other DDR factors
such as 53BP141,42. Our results suggest that a similar mechanism
may operate in NBs.
Contrasting with the impacts documented above were our
ﬁndings relating to the MDC1 proline-serine-threonine rich
(PST) repeat region, which in human cells comprises 13 imperfect
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Fig. 2 53BP1 localisation to DNA-damage sites in H2AX−/− cells depends on MDC1. a Representative immunoﬂuorescence images of 53BP1 NB formation
after 24 h of 0.4 μM aphidicolin (APH) treatment, and of 53BP1 IRIF 1 h after IR (3 Gy) exposure in wild-type RPE-1 and knockout cell lines. b Quantiﬁcation
of 53BP1-NBs and 53BP1 IRIF in cells treated as in a. Cyclin A staining was used to differentiate G1 from S/G2 cells; n= 4/genotype (except for non-treated
H2AX KO and IR MDC1 KO n= 3); error bars s.e.m.; ****p < 0.0001; two-tailed Student’s t test. c Representative immunoﬂuorescence images showing
MDC1 localisation at NBs or IRIF after APH or IR treatments (as in a) in the RPE-1 H2AX+/+ and H2AX−/− cell lines. Cyclin A staining was used to
distinguish between G1 and S/G2 cells. d Quantiﬁcations showing MDC1 localisation at NBs in the RPE-1 H2AX+/+ and H2AX−/− cell lines after 24 h
treatment with 0.4 μM APH. Cells were depleted for 53BP1, RNF8, SHLD1 or SHLD2 by siRNA for 48 h before the APH treatment; n= 3/genotype; error
bars s.e.m.; **p < 0.01; two-tailed Student’s t test. Supporting data, including quantiﬁcations of number of NBs and IRIF per cell and validation of 53BP1,
RNF8, SHLD1 and SHLD2 depletion are shown in Supplementary Fig. 2. Scale bars, 10 μm
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copies of an ~40 amino-acid-residue motif. Strikingly, deleting
this PST-repeat region had a major effect on 53BP1 NB formation
only in the absence of H2AX. Thus, while expression of MDC1-
ΔPST in MDC1−/− cells restored 53BP1 NB formation to near
normal levels, 53BP1 NBs were undetectable when MDC1-ΔPST
was expressed in MDC1−/− H2AX−/− cells (Fig. 3b; Supplemen-
tary Fig. 3a, b). In line with these observations, we found that
deleting the MDC1 PST-repeat region did not affect the
accumulation of MDC1 in NBs in otherwise wild-type cells, yet
totally abrogated MDC1 NB accrual in the absence of H2AX
(Fig. 3c; Supplementary Fig. 3c). As we had established that
residual 53BP1 IRIF formation in H2AX-/- cells requires MDC1
(Fig. 2a, b; Supplementary Fig. 2a, b), we assessed whether this
required the MDC1 PST-repeat region. Indeed, in accord with
our other data, expression of wild-type MDC1 but not MDC1-
ΔPST in the MDC1−/− H2AX−/− knockout background allowed
53BP1 IRIF formation in a subset of cells (Fig. 3d; Supplementary
Fig. 3d, e; as observed in the case of NBs, deleting the PST-repeat
region had no or only a mild effect in H2AX+/+ cells).
To address the potential biological importance of the MDC1
PST-repeat region in the H2AX-/- genetic background, we
assessed the impact of deleting this section of MDC1 on
clonogenic cell survival in response to IR exposure in both
H2AX-proﬁcient and H2AX-deﬁcient settings. As shown in
Fig. 3e, expression of wild-type MDC1 or MDC1-ΔPST
essentially fully alleviated the IR hypersensitivity of H2AX+/+
MDC−/− knockout cells. In stark contrast, while wild-type MDC1
largely alleviated the IR hypersensitivity of H2AX−/− MDC−/–
double mutant cells, MDC1-ΔPST did not (Fig. 3f). Taken
together with our other ﬁndings, these results supported a model
in which MDC1 PST-region mediated recruitment of proteins to
DSBs promotes cell survival in response to IR when H2AX is
absent.
The PST region fosters constitutive MDC1 chromatin reten-
tion. To explore the function(s) of the MDC1 PST region, we
tested whether it was recruited to DSB regions in cells when fused
to GFP either alone or together with the MDC1 BRCT domain.
As shown in Supplementary Fig. 4a, in contrast to IRIF and NB
formation by the GFP-PST-BRCT fragment, we were not able to
detect localisation of the GFP-PST construct at these sites. We
thus concluded that the function of the MDC1 PST-repeat region
is not to speciﬁcally target MDC1 to sites of DNA damage. This is
consistent with the fact that, although the accumulation of 53BP1
at sites of DNA damage is MDC1-dependent in the absence of
H2AX, we could not detect any enrichment of MDC1 itself at
IRIF in the H2AX−/− genetic background (Fig. 2c).
While MDC1 is reported to be constitutively associated with
chromatin independently of DNA damage43, to our knowledge, no
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function has so far been established for this association. To evaluate
whether the PST region might bind chromatin, we performed
chromatin fractionation studies on MDC1−/− H2AX+/+ and
MDC1−/− H2AX−/− U2OS cells (Supplementary Fig. 4b–d)
transfected with constructs expressing GFP alone or GFP fused to
the MDC1 PST-repeat region. Strikingly, in contrast to GFP alone,
the PST-GFP protein was enriched in the chromatin fraction in a
manner that was independent of H2AX status (Fig. 4a). We noticed
that, when overexpressed, the GFP-PST protein accumulated in
areas of the nucleus resembling nucleoli (Supplementary Fig. 4a).
However, it is unlikely that this localisation was responsible for the
association of the GFP-PST fragment to chromatin fractions, as the
apparent nucleolar localisation was lost when cells were detergent
pre-extracted before ﬁxation (with a similar buffer to the one used
for chromatin fractionation) while the rest of the nuclear GFP-PST
remained resistant to pre-extraction (Supplementary Fig. 4e). In line
with this conclusion, when we carried out immunoprecipitation
studies with cell extracts expressing GFP or the GFP-PST fusion
construct, the latter but not the former co-immunoprecipitated with
all four core histones (Fig. 4b).
The above ﬁndings showed that the MDC1 PST-repeat region
directly or indirectly binds chromatin. To see whether this region
was necessary for chromatin association by MDC1, we trans-
fected H2AX−/− MDC1−/− U2OS cells with plasmids expressing
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Fig. 4 MDC1 PST region binds nucleosomes and promotes DNA damage-independent association of MDC1 with chromatin. a Chromatin fractionation of
U2OS MDC1−/− and MDC1−/− H2AX−/− cells transfected with plasmids expressing a GFP-PST construct or GFP-only. b GFP pulldowns from extracts of
U2OS MDC1−/− H2AX−/− cells expressing GFP-PST or GFP-only were analysed by western blotting using antibodies against the four core histones and
GFP. c Representative image of chromatin fractionation of U2OS MDC1−/− H2AX−/− cells transfected with plasmids expressing GFP-tagged full-length or
ΔPST versions of MDC1 (top panel) and quantiﬁcation of the relative MDC1 abundance in each fraction (lower panel); n= 4; error bars s.e.m. As previously
reported47, we found that GFP-MDC1ΔPST mutant protein was expressed in much higher amounts than wild-type GFP-MDC1, implying that the PST region
promotes MDC1 turnover. To normalise protein levels, we harvested cells at 48 h after transfection for full-length MDC1 and at 8 h after transfection in the
case of ΔPST-MDC1 (Supplementary Fig. 4f). d Western blot to detect the 4 core histones in samples derived from biochemical binding assays between
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and PST-DNA binding assays
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GFP fused to full-length MDC1 (GFP-MDC1) or GFP fused to
MDC1 bearing a deletion of the PST-repeat region (GFP-
MDC1ΔPST). Notably, while wild-type MDC1 robustly asso-
ciated with chromatin, this association was much less strong in
the context of MDC1 lacking the PST-repeat region, where most
of the protein remained in the soluble, non-chromatin fraction
(Fig. 4c). Collectively, these results pointed to a hitherto
unreported role for the MDC1 PST region in mediating DNA-
damage independent association of MDC1 with chromatin.
The MDC1 PST region interacts with the nucleosome acidic
patch. While our previous data had established that the MDC1
PST-repeat region binds chromatin, they did not show whether
this binding was direct, or which histone or histone(s) might be
involved in the interaction. To address these issues, we carried out
in vitro binding assays with puriﬁed GFP-PST fusion protein
derived from transfected HEK293 cells and commercial recom-
binant core histones expressed in and puriﬁed from E. coli and
thereby lacking posttranslational modiﬁcations (PTMs). Notably,
we did not detect binding of the MDC1 PST fragment to any of
the recombinant histones (Supplementary Fig. 4g). We reasoned
that the observed binding of the PST region to chromatin derived
from cells but not recombinant histones could reﬂect indirect
binding to chromatin via a factor that was not present in the
recombinant histone preparation, chromatin binding requiring a
histone PTM that was not present in the recombinant histones, or
chromatin binding requiring more than one histone or even an
intact nucleosome structure. To explore these possibilities, we
carried out binding assays with histones puriﬁed from calf thy-
mus, which carry PTMs, and with mono-nucleosomes puriﬁed
from HeLa cells. Strikingly, the PST region did not bind any
histone from the mammalian histone mix, but efﬁciently retrieved
all four core histones from the preparation of mono-nucleosomes
(Fig. 4d; Supplementary Fig. 4h). These data thus indicated that
the MDC1 PST region binds chromatin directly, and furthermore
suggested that this association is not mediated by a single histone
but needs the whole nucleosome complex.
An obvious difference between the nucleosomes and the
puriﬁed histones used in the above studies is the former but not
the latter contain DNA that wraps around the histones to
generate a stable histone octamer. However, we did not detect
binding of the MDC1 PST region to sepharose beads bearing a
DNA oligonucleotide (Supplementary Fig. 4i; note binding of the
known DNA-binding protein PARP1 to beads bearing DNA but
not native beads). These data suggested that PST-mediated
MDC1 binding to nucleosomes and chromatin is unlikely to arise
through DNA binding or, at least through DNA binding alone.
Given that the PST region is positively charged (isoelectric point
of 9.85; Isoelectric.org), we noted that several chromatin-
interacting proteins recognise a negatively charged region of the
nucleosome termed the acidic patch, formed by residues in both
histone H2A and H2B17,44,45. We therefore explored whether the
acidic patch was required for the PST-nucleosome interaction by
performing binding assays with reconstituted recombinant
nucleosomes. Thus, we observed that mutating key residues in
the acidic patch dramatically reduced PST region binding to
nucleosomes (Fig. 5a, b). These ﬁndings therefore highlighted
roles for H2A-H2B acidic patch residues in mediating MDC1
PST-repeat region binding. Nevertheless, the PST fragment still
had some residual binding to acidic-patch mutant nucleosomes
(Fig. 5b), meaning that the MDC1-PST region might also mediate
additional interactions with other surface(s) of the nucleosome.
All the chromatin/nucleosome-binding experiments described
above were performed with the full-length PST region, composed
of 13 degenerate copies of the ~40 amino-acid-residue repeat
motif. We next investigated whether one repeat was enough to
mediate nucleosome association or whether more than one repeat
was needed for effective binding. To do this, we transfected
HEK293 cells with constructs encoding GFP fused to the full-
length (FL) MDC1 PST region (containing 13 repeats) or
truncated GFP-fusion constructs containing 0, 1, 2 or 5 repeats.
We then afﬁnity-puriﬁed the proteins and tested them for their
ability to bind nucleosomes in vitro. As shown in Fig. 5c, the
protein containing 5 PST repeats bound puriﬁed mono-nucleo-
somes, although with lower efﬁciency than the full-length PST
region, while undetectable binding was observed for GFP alone or
the proteins containing 1 or 2 PST repeats. Complementary
results were obtained when we carried out chromatin-
fractionation studies with extracts of cells expressing GFP or
the different GFP-PST derivatives: only the protein with 5 PST
repeats bound chromatin detectably and this binding was less
effective than exhibited by the full-length PST region (Fig. 5d). As
discussed further below, these results suggest a cooperative
binding model in which strong binding is brought about via
multiple MDC1 PST repeats interacting with multiple acidic
patches, and perhaps other nucleosome surfaces.
Discussion
MDC1 is a key DDR protein, which functions by binding γH2AX
and mediating localisation of the ubiquitin E3 ligases RNF8 and
RNF168 to DNA damage sites, thereby promoting ubiquitylation
of histone H2A and the ensuing recruitment of various DDR
components, including 53BP1 and BRCA1. Here, we have shown
that MDC1 functions in the DDR do not fully depend on its
association with γH2AX, thus helping to explain the higher IR
sensitivity of MDC1−/− knockout cells as compared to H2AX−/−
cells. Our results also imply that MDC1 promotes survival to
DNA damage in the absence of H2AX via its ability to help
recruit repair factors to DSB regions. Furthermore, we have
established that DNA-damage independent MDC1 association
with chromatin is largely mediated by its PST-repeat region, a
region that does not have any discernible impact on IR survival in
a H2AX+/+ background but becomes important for IR survival in
H2AX−/− cells. These observations thus support a model in
which chromatin binding by MDC1 mediates a DDR that mini-
mises the toxicity of DNA damage when the canonical γH2AX-
MDC1 axis is not available.
The PST-repeat region of MDC1 is conserved in vertebrates,
although the number of repeats varies considerably between
species (for example, 13 in human and 7 in mouse). It does not
contain known structural or functional motifs and does not
appear to display sequence homology to any other protein.
Notably, previous studies have described DSB repair defects in
cell lines carrying ΔPST mutant MDC1 alleles46,47. Furthermore,
it was reported that the MDC1 PST region interacts with the Ku/
DNA-PKcs (DNA-PK) complex and that this interaction is
required for DNA-PKcs autophosphorylation and for DSB repair
by non-homologous end joining (NHEJ), as measured by random
plasmid integration assays46. However, we have been unable to
observe any defect in the kinetics or extent of DNA-PKcs, CHK2
or KAP1 phosphorylation in our MDC1−/− or MDC1−/−
H2AX−/− knockout cells as compared to wild-type controls. It
was unexpected to observe no overt DDR defects in the absence
of MDC1, although in support of our observations, a recent study
similarly did not report signalling deﬁciencies inMDC1−/− U2OS
cells27. Early literature on MDC1 reported contradictory effects of
MDC1 depletion on the DDR signalling pathway, with some
papers describing reduced phosphorylation of certain DDR fac-
tors and other papers showing a larger effect on other phos-
phorylations30–32,48. One explanation for the discrepancies
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between our observations and some previous reports could be off-
target effects of siRNAs used in the previous studies and/or the
adaptation experienced by our cell lines after we had inactivated
the MDC1 gene. Furthermore, we have observed no discernible
differences in DDR-factor phosphorylations between MDC1−/−
H2AX−/− knockout cells complemented with MDC1-WT or
MDC1-ΔPST constructs (Supplementary Fig. 5), implying that IR
hypersensitivity observed in MDC1-deﬁcient backgrounds is not
caused by defects in the phosphorylation cascade triggered by
DNA damage induction. In addition, we observed an effect of the
MDC1-ΔPST allele on cell survival only in H2AX-deﬁcient
backgrounds, while DNA-PKcs/NHEJ defects are known to
impact on cell survival when H2AX is present49,50. Collectively,
our data point to chromatin binding by the MDC1 PST-repeat
region as acting in an H2AX-independent manner to enhance cell
survival via promoting the functions of 53BP1 and its down-
stream effectors at sites of DNA damage and perhaps the adjacent
chromatin regions.
Mechanistically, we have shown that mutations in key residues
in the nucleosome acidic patch, comprised by amino acids of
H2A and H2B, severely impair the binding of the MDC1 PST-
repeat region to nucleosomes in vitro. This result implies that the
PST region interacts with the acidic patch of nucleosomes to
promote chromatin association of MDC1 and associated factors
in cells, a conclusion supported by our chromatin-fractionation
data. It is notable that our work has shown more than two MDC1
PST repeats are needed to mediate effective binding to cellular
chromatin or to nucleosomes in vitro. While these observations
are consistent with the fact that all vertebrate MDC1 homologues
studied contain many PST repeats, they are puzzling because a
nucleosome only contains two acidic patches. Our observations
might therefore suggest that several repeats could interact coop-
eratively with the same acidic patch, or perhaps more plausibly,
that certain PST repeats act as spacers to allow two non-adjacent
PST repeats to interact simultaneously and cooperatively with
two acidic patches on the opposing faces of a nucleosome. It is
also tempting to speculate that the entire MDC1 PST region may
make contacts with multiple adjacent nucleosomes in a way to
change chromatin characteristics and inﬂuence the binding of
other chromatin components. Clearly, more detailed biochemical,
biophysical and structural studies will be needed to test these
ideas and explore their potential impacts on chromatin organi-
sation. In this regard, it is important to recognise that in addition
to MDC1, several other proteins are known to interact with the
acidic patch region of the nucleosome51, although effective
nucleosome binding by some of these, such as 53BP1 and
RNF169, requires recognition of histone modiﬁcations in addi-
tion to the acidic patch itself17,52. In light of this and
our ﬁndings, it will be interesting to examine if the H2AX-
independent interaction between MDC1 and nucleosomes can be
modulated by any histone posttranslational modiﬁcation and/or
whether MDC1 interactions with nucleosomes function syner-
gistically or antagonistically with other nucleosome-binding
proteins.
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Taken together, our data suggest an important role for the
MDC1 PST region in an H2AX-independent pathway to activate
DDR factors at sites of DNA damage by a mechanism under-
pinned by MDC1 binding chromatin in a DNA-damage inde-
pendent fashion. While it is difﬁcult to envision how evolution
could maintain such an alternative mechanism if it is relevant
only in cells lacking H2AX, we note that the distribution of the
H2AX variant histone along the genome is not homogeneous,
with large areas of the human genome appearing to be largely or
completely depleted of H2AX53. As we have shown that MDC1
constitutive binding to chromatin does not depend on H2AX, it is
tempting to speculate that the importance of PST-repeat region
mediated MDC1 chromatinization is to facilitate DDR activation
when DSBs occur in such regions, with DSB-tethered MRN and
ATM triggering MDC1 phosphorylations in the vicinity of the
breaks and ensuing events in these settings. Further studies will be
needed to test this and other hypotheses.
Methods
Cell culture. RPE-1 FRT-derived cells were cultured in F12 (Ham’s F12; Sigma-
Aldrich) supplemented with 17 ml NaHCO3 7.5% per 500 ml (Sigma-Aldrich).
U2OS-derived and HEK293 cells were cultured in Dulbecco’s modiﬁed Eagle
medium (DMEM; Sigma-Aldrich).
All media were supplemented with Tet-free 10% (vol/vol) fetal bovine serum
(Life Technologies Ltd), 100 Uml−1 penicillin, 100 µg ml−1 streptomycin (Sigma-
Aldrich) and 2 mM L-glutamine. For maintenance of the RPE-1 FRT-derived cells
expressing GFP-tagged constructs, 0.5 mg ml−1 G418 (Invitrogen) was used. All
cells were originally obtained from the ATCC cell repository and routinely tested
for mycoplasma.
Generation of human stable cell lines and knockouts. FRT-derived cells stably
expressing inducible GFP-tagged constructs were generated by transfection of
pcDNA5/FRT/TO-neo containing the GFP-tagged construct and pOG44 (1:4,
respectively). Selection began after 48 h using 0.5 mgml−1 G418 (Invitrogen).
H2AX knockout was generated in RPE-1 FRT cells, by co-transfection with an All-
in-one plasmid54, containing the gRNAs and the nickase Cas9 gene, and a donor
plasmid with two H2AX homology arms ﬂanking a cassette with GFP and
puromycin-resistance genes. The sequences of the DNA oligonucleotides used to
generate the guide-RNAs are listed in Supplementary Table 1. After puromycin
selection, single-cell sorting by GFP expression was carried out using MoFlo
(Beckman Coulter) to select for transfected cells. Single clones were expanded and
screened by western blotting.
Deletion of H2AX in the RPE-1 FRT MDC1 null54, U2OS or U2OS MDC1
null54 cells was carried out by transfection of the same All-in-one plasmid, without
using any donor plasmid. GFP-expressing cells were single-cell sorted, expanded
and screened by western blotting.
H2AX DNA from candidate clones was ampliﬁed by PCR using the primers
H2AFX Fwd and H2AFX Rev, and the PCR products were Topo-cloned and
Sanger-sequenced using the primers H2AX seq1 Fw, H2AX seq1 Rv, H2AFX Fwd
and H2AFX Rev (Supplementary Table 2).
Plasmids. Plasmids used to stably integrate the GFP-tagged constructs into
FRT cells were generated as follows: The GFP-tagged MDC1 wild type and mutant
versions were obtained by PCR from plasmids previously described in refs. 5,6,11.
PCR products were then cloned into the pcDNA5/FRT/TO-neo plasmid. In order
to generate the GFP-PST and GFP-PST-BRCT expression vectors the corre-
sponding fragments (1120–1667 for PST and 1120–2089 for PST-BRCT) were
ampliﬁed from the pcDNA3.1-GFP-MDC1 plasmid11 and cloned into the pEGFP-
C1 vector. To create the pEGFP-C1-1X-PST, pEGFP-C1-2X-PST and pEGFP-C1-
5X-PST plasmids the truncated PST fragments were ampliﬁed from the pEGFP-
C1-PST vector using the primers EGFP-C, PST_r2_R and PST_r6_R (Supple-
mentary Table 2).
Bands of the correct sizes were cut from the gel, puriﬁed, digested with SmaI
and BsrGI, and cloned into pEGFP-C1. All the constructs were veriﬁed by Sanger
sequencing.
siRNA and plasmid transfection. Plasmid transfections were carried out using
TransIT-LT1 (Mirus Bio) according to the manufacturer’s protocol. RPE-1 cells
were transfected with siRNAs obtained from MWG using Lipofectamine RNAi-
MAX (Invitrogen) following the manufacturer's instruction. The siRNA ﬁnal
concentration was 60 nM. The sequences of siRNAs (ThermoFisher) are listed in
Supplementary Table 3.
DNA-damage induction. For induction of 53BP1 nuclear bodies, aphidicolin
(Sigma-Aldrich) 0.4 μM was added for 24 h. Ionising radiation treatments at the
indicated doses were performed with a Faxitron-CellRad (Faxitron Bioptics, LLC)
machine. In the case of the FRT-derived cells, expression of all the GFP-tagged
constructs was induced two days before the start of any treatment (APH or IR) by
addition of doxycycline to a ﬁnal concentration of 0.5 μg ml−1. The cells were
maintained in the presence of doxycycline for the whole duration of the
experiment.
Clonogenic survival assays. The day before treatment, cells were seeded in 6-well
plates at 500 or 1000 cells per well and three replicates per condition. For the cell
lines where a poor survival was expected, 5000 cells were seeded for the highest
dose. Upon treatment with IR at the appropriate dose, cells were incubated for
7–10 days, stained with crystal violet, and the number of colonies per well was
counted and normalised to the initial number of cells. For all experiments, data
were normalised to the untreated conditions to consider variations in plating
efﬁciency. Only colonies with more than 30 cells were considered as proper
colonies and therefore counted.
Whole-cell extracts and immunoblotting. Whole cell lysates were prepared by
scraping cells in 2xSDS buffer (120 mM Tris-HCl pH 6.8, 4% SDS, 20% glycerol).
Protein concentration was determined with Nanodrop One (Thermo Scientiﬁc)
and 30 μg run in 4–12% Bis-Tris NuPAGE precast gels. Separated proteins
were transferred to nitrocellulose (GE Healthcare) and immunoblotted with
the indicated antibodies. A list of all antibodies used in this study can be found
in Supplementary Table 4. All uncropped images are provided in Supplementary
Fig. 6a, b.
Immunoprecipitation. MDC1−/− H2AX−/− U2OS cells were transfected with
GFP-PST or GFP-only expressing plasmids and pull-down experiments were
carried out two days later. Immunoprecipitation was performed as follows: cells
were lysed in benzonase buffer (20 mM Tris-HCl pH 7.5, 40 mM NaCl, 2 mM
MgCl2, 10% Glycerol, 0.5% Igepal, EDTA-free protease inhibitors (Roche, 1 tablet
per 50 ml), EGTA-free phosphatase inhibitors (1 mM NaF, 0.7 mM β-glycerol
phosphate, 0.2 mM Na3VO4, 8.4 mM Na4P2O7), benzonase (Novagen, 3 μl per ml),
3 mM 1,10-phenanthroline, 10 mM N-ethylmaleimide) for 15 min at room tem-
perature. The NaCl concentration was then increased to 500 mM prior to incu-
bating on ice for 20 min. The lysate was then centrifuged at 20000 g for an hour at
4 °C and the supernatant was transferred to a new tube. Salt concentration was
adjusted to 150 mM with benzonase buffer and protein concentrations were
determined by Bradford assay and adjusted to the lowest concentrated sample with
buffer. The protein extracts were then mixed with previously washed and equili-
brated GFP-Trap beads (Chromotek, 10 μl per milligram of protein) and rotated
overnight at 4 °C. Next day, beads were centrifuged for 2 min at 4 °C and washed
with benzonase buffer (without benzonase and containing a ﬁnal concentration of
200 mM NaCl). After ﬁve more washes with the same buffer, proteins were eluted
from the GFP-Trap beads in a 5–10-min incubation step at 95 °C in 1.5 × SDS
sample buffer and immunoblotted as described in the respective section.
DNA pull-down. Magnetic streptavidin Dynabeads (Dynal, M-280; 50 μl bead-
slurry per reaction) were washed twice with 2 × Binding and Washing buffer (2 ×
B&W buffer; 10 mM Tris-HCl pH 7.4 and 2M NaCl) and subsequently rotated for
15 min at room temperature in the presence of 5 pmol of 5′-biotinylated oligonu-
cleotides of the sequence 5′-Biotin-GCCTACCGGTTCGCGAACCGGTAGGC3′.
After washing three times with 1 × B&W, DNA-bound beads were incubated
overnight at 4 °C with whole cell lysate prepared as follows: HEK293 cells trans-
fected with either GFP-PST or GFP-only expressing plasmids were lysed in ben-
zonase buffer (the same as used for immunoprecipitations) for 15min at room
temperature. The NaCl concentration was then adjusted to 150mM and EDTA was
added to a ﬁnal concentration of 10 mM to inactivate the benzonase prior to
incubating on ice for 20min. The lysate was then centrifuged at 20,000 × g for an
hour at 4 °C and the supernatant was then mixed with the DNA-coated beads. After
binding, the beads were washed ﬁve times with the same buffer (without benzonase)
and boiled in 1.5 × Laemmli buffer with ß-mercaptoethanol and bromophenol blue
to release the proteins from the beads.
GFP-PST puriﬁcation and nucleosome pull-down. HEK293 cells transfected with
either GFP-PST or GFP-only expressing plasmids were lysed in benzonase buffer
(the same as used for immunoprecipitations) for 15 min at room temperature.
Subsequently, the NaCl and Igepal concentrations were increased to 1 M and 1%
respectively and samples incubated for 20 min on ice. After centrifugation for 1 h at
20,000 × g at 4 °C, the supernatant was transferred to new tubes and mixed with
previously washed and equilibrated GFP-Trap beads (Chromotek). Lysates and
beads were rotated at room temperature for 1 h and then washed ten times with the
high salt and detergent benzonase buffer (without benzonase). The beads were then
washed three more times with binding buffer (10 mM Tris pH7.5, 150 mM NaCl,
0.5% NP40, 0.5 mM EDTA) and suspended in 0.5 ml of the same buffer. In all, 5 μg
of nucleosome (Epicypher) or histone mix (Sigma-Aldrich) were added to the
beads and rotated overnight at 4 °C. Next morning the beads were washed ﬁve
times with binding buffer and proteins were eluted by boiling in Laemmli buffer
with ß-mercaptoethanol and bromophenol blue.
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-019-12929-5 ARTICLE
NATURE COMMUNICATIONS |         (2019) 10:5191 | https://doi.org/10.1038/s41467-019-12929-5 | www.nature.com/naturecommunications 9
Silver staining. Silver staining was performed with the SilverQuest™ Silver Staining
Kit (Invitrogen) following the manufacturer’s recommendations.
Immunoﬂuorescence staining. Cells were grown on poly-lysine-coated coverslips
for treatments with IR or aphidicolin. Following treatment, cells were washed with
PBS 0.1% Tween and ﬁxed without pre-extraction with 2% paraformaldehyde in
PBS for 20 min at room temperature. Samples were then permeabilised with PBS
0.5% Triton for 15 min, blocked in 5% bovine serum albumin in PBS and stained
with the appropriate primary antibody (Supplementary Table 4) and secondary
antibodies coupled to Alexa Fluor 488, 594 or 647 (Molecular Probes). When
samples were subjected to pre-extraction, coverslips were incubated with pre-
extraction buffer (25 mM HEPES pH 7.4, 50 mM NaCl, 1 mM EDTA, 3 mM
MgCl2, 300 mM sucrose and 0.5% Triton X-100) for 15 min on ice and then
washed with PBS and ﬁxed as above. Pre-extracted samples did not require further
permeabilization, so that step was omitted. Confocal images were captured on a
Leica SP8 confocal microscope with a ×40 or ×60 oil objective lens and processed
by ImageJ (version 2.0.0) and quantiﬁed by Volocity 6.3 (PerkinElmer).
Automated high-throughput/high-content microscopy. For nuclear bodies and
IRIF quantiﬁcations, cells were seeded into 96-well plates (Cell Carrier, Perkin Elmer)
at a density of 10,000 cells per well. The following day, cells were either mock treated,
treated with aphidicolin or irradiated (3 Gy). Plates were ﬁxed at the indicated time
points and stained with the respective antibodies and DAPI. A spinning-disc Perkin
Elmer Opera platform equipped with a ×40 water immersion objective was employed
to acquire 10 confocal images (ﬁelds) for each well in a single optimised focal plane
comprising two ﬂuorescence channels, DAPI and Alexa Fluor 488. The micrographs
were analysed using an optimised spot detection script operated by an integrated
software package (Harmony 4.8, Perkin Elmer). DAPI was used to segment nuclei and
create a nuclear mask. In the case of nuclear body quantiﬁcation, cyclin A positive
cells were excluded and the percentage of 53BP1-IRIF positive or 53BP1-NBs positive
cells calculated. For FRT cell lines expressing the GFP-MDC1 constructs, only GFP-
positive cells were taking into account in the ﬁnal population. More than 500 cells
were counted per condition and repeat.
Cell cycle proﬁling. Cells were collected after a 30min pulse with 10 μM EdU,
washed with ice-cold PBS and ﬁxed for 30min with 2% paraformaldehyde in PBS.
After washing with PBS-B (1xPBS+ 1mgml−1 BSA), cells were permeabilized with
PBS-T (1 × PBS+ 0.2% Triton X-100) and incubated with the Click reaction cocktail
(2 mM CuSO4, 1 μM Alexa FluorTM 488 Azide (Invitrogen), 10mM sodium L-
ascorbate, in PBS) for 30min at room temperature in the dark. Finally, cells were
washed with PBS-B and suspended in FACS buffer (0.02% NaAz, 250 μgml−1 RNase,
3.2 ngml−1 DAPI, in PBS-B). Flow cytometry was performed with an Attune NxT
machine (Invitrogen) and analysed with FlowJo software (BD Inc, USA).
Chromatin fractionation. Cells were collected from plates, washed with cold PBS
and suspended in CSK buffer (10 mM PIPES pH 7.0, 100 mM NaCl, 300 mM
sucrose, 3 mM MgCl2, protein inhibitor cocktail (Roche, EDTA-free), phosphatase
inhibitors (EGTA-free, same as for benzonase buffer), 0.7% Triton X-100). After
30 min incubation on ice, the lysate was centrifuged at 20,000 × g for 10 min at 4 °
C. The supernatant (soluble fraction) was collected and kept on ice. The pellet was
washed with cold PBS, suspended in CSK buffer and sonicated for four pulses of 10
s at 30% amplitude with 10 s resting on ice between cycles. This sonicated solution
is the chromatin fraction. Laemmli buffer was added to the soluble and the
chromatin fractions and both samples were boiled and centrifuged for 1 min at
16,000 × g in a table-top centrifuge. In total, 30–50 μg of total protein from each
fraction were loaded onto SDS-PAGE gels.
Recombinant nucleosome generation. Deﬁned recombinant nucleosome core
particles (NCPs) were generated essentially as described17. Histone variants were
mutated by site-directed mutagenesis to introduce acidic patch mutations and
remove cysteines in histone H3. Brieﬂy, individual core human histones and his-
tone variants (H2A.1, H2A.1 e65A E90A E91A; H2B.1, H3.1 C110A, C96S, R134C,
H4) were expressed in BL-21 DE3 RIL E. coli and histones were puriﬁed from
inclusion bodies via cation exchange chromatography55, dialysed into water sup-
plemented with 1 mM acetic acid and lyophilised for storage at −20 °C. Pure
histones were mixed at an equimolar ratio and dialysed into a high salt buffer (2 M
NaCl, 15 mM Tris pH 7.5, 1 mM DTT). Octamers containing fractions were
selected by size exclusion chromatography (HiLoad HiLoad Superdex 200 16/600
GE healthcare S200) and concentrated in 30 kDa MWCO spin concentrator
(Amicon). 169 bp of Widom-603 strong nuclear positioning DNA was generated
by PCR using Pfu polymerase and HPLC-grade oligonucleotides essentially as
described56 . In all, 100 μl PCR products from 384 reactions were pooled and
puriﬁed on a ResorceQ column (GE Healthcare) and 169 bp product fractions
concentrated by ethanol precipitation. NCPs were reconstituted by slow gradient
dialysis of equimolar DNA and histone octamers into low salt buffer55 (15 mM
HEPEs pH 7.5, 200 mM KCl, 1 mM DTT, 1 mM EDTA), prior to a ﬁnal dialysis in
storage buffer (15 mM HEPEs pH 7.5, 100 mM NaCl, 1 mM EDTA, 1 mM DTT).
Soluble NCPs were concentrated using a 100-kDa cut-off spin concentrator
(Amicon). NCP formation and purity were conﬁrmed by native polyacrylamide gel
electrophoresis and NCPs were stored at 4 °C and used within one month of
assembly.
Statistics. Statistical analysis (Two-tailed Student’s t tests) in all graphs of this
work were calculated using GraphPad Prism version 8 for Mac OS X, GraphPad
Software (La Jolla, CA, USA).
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
All relevant data are available from the authors upon request. The source data
underlying. Figs. 1b, 2b, d, 3b–f, and 4c are provided as a Source Data ﬁle.
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